Article
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
The Journal of clinical endocrinology and metabolism - 1 Sept 2004
Lima Jorge, Trovisco Vítor, Soares Paula, Máximo Valdemar, Magalhães João, Salvatore Giuliana, Santoro Massimo, Bogdanova Tatyana, Tronko Mykola, Abrosimov Alexander, Jeremiah Steve, Thomas Gerry, Williams Dillwyn, Sobrinho-Simões Manuel
Abstract excerpt
The BRAF gene has been shown to be a major target for mutations in papillary thyroid carcinoma (PTC) (36-69%), which forms almost all of the over 2000 cases of thyroid carcinoma that have occurred in Chernobyl. BRAF is activated by point mutation, and were it to occur at a high frequency in Chernobyl-related tumors, it would challenge the dominant role of double-strand breaks in radiation-induced PTC. In a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
